Literature DB >> 23817550

The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry.

Martin E Hess1, Simon Hess, Kate D Meyer, Linda A W Verhagen, Linda Koch, Hella S Brönneke, Marcelo O Dietrich, Sabine D Jordan, Yogesh Saletore, Olivier Elemento, Bengt F Belgardt, Thomas Franz, Tamas L Horvath, Ulrich Rüther, Samie R Jaffrey, Peter Kloppenburg, Jens C Brüning.   

Abstract

Dopaminergic (DA) signaling governs the control of complex behaviors, and its deregulation has been implicated in a wide range of diseases. Here we demonstrate that inactivation of the Fto gene, encoding a nucleic acid demethylase, impairs dopamine receptor type 2 (D2R) and type 3 (D3R) (collectively, 'D2-like receptor')-dependent control of neuronal activity and behavioral responses. Conventional and DA neuron-specific Fto knockout mice show attenuated activation of G protein-coupled inwardly-rectifying potassium (GIRK) channel conductance by cocaine and quinpirole. Impaired D2-like receptor-mediated autoinhibition results in attenuated quinpirole-mediated reduction of locomotion and an enhanced sensitivity to the locomotor- and reward-stimulatory actions of cocaine. Analysis of global N(6)-methyladenosine (m(6)A) modification of mRNAs using methylated RNA immunoprecipitation coupled with next-generation sequencing in the midbrain and striatum of Fto-deficient mice revealed increased adenosine methylation in a subset of mRNAs important for neuronal signaling, including many in the DA signaling pathway. Several proteins encoded by these mRNAs had altered expression levels. Collectively, FTO regulates the demethylation of specific mRNAs in vivo, and this activity relates to the control of DA transmission.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817550     DOI: 10.1038/nn.3449

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  46 in total

1.  Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice.

Authors:  G Díaz-Torga; C Feierstein; C Libertun; D Gelman; M A Kelly; M J Low; M Rubinstein; D Becú-Villalobos
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

Review 2.  New insights into dopaminergic receptor function using antisense and genetically altered animals.

Authors:  D R Sibley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

3.  G protein-activated inwardly rectifying K+ (GIRK) currents in dendrites of rat neocortical pyramidal cells.

Authors:  T Takigawa; C Alzheimer
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

4.  Inverse association of the obesity predisposing FTO rs9939609 genotype with alcohol consumption and risk for alcohol dependence.

Authors:  Agnieszka Sobczyk-Kopciol; Grazyna Broda; Marcin Wojnar; Pawel Kurjata; Andrzej Jakubczyk; Anna Klimkiewicz; Rafal Ploski
Journal:  Addiction       Date:  2010-12-23       Impact factor: 6.526

5.  Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons.

Authors:  Mats I Ekstrand; Mügen Terzioglu; Dagmar Galter; Shunwei Zhu; Christoph Hofstetter; Eva Lindqvist; Sebastian Thams; Anita Bergstrand; Fredrik Sterky Hansson; Aleksandra Trifunovic; Barry Hoffer; Staffan Cullheim; Abdul H Mohammed; Lars Olson; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

6.  Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons.

Authors:  Kate D Meyer; Yogesh Saletore; Paul Zumbo; Olivier Elemento; Christopher E Mason; Samie R Jaffrey
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

7.  Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments.

Authors:  B T Hope; H E Nye; M B Kelz; D W Self; M J Iadarola; Y Nakabeppu; R S Duman; E J Nestler
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

Review 8.  Genetics of dopamine receptors and drug addiction: a comprehensive review.

Authors:  Bernard Le Foll; Alexandra Gallo; Yann Le Strat; Lin Lu; Philip Gorwood
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

9.  An obesity-associated FTO gene variant and increased energy intake in children.

Authors:  Joanne E Cecil; Roger Tavendale; Peter Watt; Marion M Hetherington; Colin N A Palmer
Journal:  N Engl J Med       Date:  2008-12-11       Impact factor: 91.245

10.  Variation in FTO contributes to childhood obesity and severe adult obesity.

Authors:  Christian Dina; David Meyre; Sophie Gallina; Emmanuelle Durand; Antje Körner; Peter Jacobson; Lena M S Carlsson; Wieland Kiess; Vincent Vatin; Cecile Lecoeur; Jérome Delplanque; Emmanuel Vaillant; François Pattou; Juan Ruiz; Jacques Weill; Claire Levy-Marchal; Fritz Horber; Natascha Potoczna; Serge Hercberg; Catherine Le Stunff; Pierre Bougnères; Peter Kovacs; Michel Marre; Beverley Balkau; Stéphane Cauchi; Jean-Claude Chèvre; Philippe Froguel
Journal:  Nat Genet       Date:  2007-05-13       Impact factor: 38.330

View more
  208 in total

1.  An Obesity-Predisposing Variant of the FTO Gene Regulates D2R-Dependent Reward Learning.

Authors:  Meltem Sevgi; Lionel Rigoux; Anne B Kühn; Jan Mauer; Leonhard Schilbach; Martin E Hess; Theo O J Gruendler; Markus Ullsperger; Klaas Enno Stephan; Jens C Brüning; Marc Tittgemeyer
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

Review 2.  Epigenetic regulation in Parkinson's disease.

Authors:  Catherine Labbé; Oswaldo Lorenzo-Betancor; Owen A Ross
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

3.  FTO-Dependent N 6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling.

Authors:  Hao Huang; Yinu Wang; Manoj Kandpal; Guangyuan Zhao; Horacio Cardenas; Yanrong Ji; Anusha Chaparala; Edward J Tanner; Jianjun Chen; Ramana V Davuluri; Daniela Matei
Journal:  Cancer Res       Date:  2020-06-30       Impact factor: 12.701

Review 4.  The epitranscriptome and synaptic plasticity.

Authors:  Mathieu N Flamand; Kate D Meyer
Journal:  Curr Opin Neurobiol       Date:  2019-05-17       Impact factor: 6.627

5.  FTO: linking m6A demethylation to adipogenesis.

Authors:  Moshe Shay Ben-Haim; Sharon Moshitch-Moshkovitz; Gideon Rechavi
Journal:  Cell Res       Date:  2014-12-05       Impact factor: 25.617

Review 6.  Novel RNA modifications in the nervous system: form and function.

Authors:  John S Satterlee; Maria Basanta-Sanchez; Sandra Blanco; Jin Billy Li; Kate Meyer; Jonathan Pollock; Ghazaleh Sadri-Vakili; Agnieszka Rybak-Wolf
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

7.  FTO controls reversible m6Am RNA methylation during snRNA biogenesis.

Authors:  Jan Mauer; Miriam Sindelar; Vladimir Despic; Théo Guez; Ben R Hawley; Jean-Jacques Vasseur; Andrea Rentmeister; Steven S Gross; Livio Pellizzoni; Françoise Debart; Hani Goodarzi; Samie R Jaffrey
Journal:  Nat Chem Biol       Date:  2019-02-18       Impact factor: 15.040

Review 8.  Genetic and epigenetic control of metabolic health.

Authors:  Robert Wolfgang Schwenk; Heike Vogel; Annette Schürmann
Journal:  Mol Metab       Date:  2013-09-25       Impact factor: 7.422

9.  Evolving insights into RNA modifications and their functional diversity in the brain.

Authors:  Sarah Nainar; Paul R Marshall; Christina R Tyler; Robert C Spitale; Timothy W Bredy
Journal:  Nat Neurosci       Date:  2016-09-27       Impact factor: 24.884

Review 10.  m6A RNA Methylation Controls Neural Development and Is Involved in Human Diseases.

Authors:  Kunzhao Du; Longbin Zhang; Trevor Lee; Tao Sun
Journal:  Mol Neurobiol       Date:  2018-06-16       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.